These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19537782)

  • 1. Bioresponsive, cell-penetrating, and multimeric MR contrast agents.
    Major JL; Meade TJ
    Acc Chem Res; 2009 Jul; 42(7):893-903. PubMed ID: 19537782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimeric Near IR-MR Contrast Agent for Multimodal In Vivo Imaging.
    Harrison VS; Carney CE; MacRenaris KW; Waters EA; Meade TJ
    J Am Chem Soc; 2015 Jul; 137(28):9108-16. PubMed ID: 26083313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multimeric MR-optical contrast agent for multimodal imaging.
    Harrison VS; Carney CE; Macrenaris KW; Meade TJ
    Chem Commun (Camb); 2014 Oct; 50(78):11469-71. PubMed ID: 25137290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
    Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavable β-cyclodextrin nanocapsules incorporating Gd(III)-chelates as bioresponsive MRI probes.
    Martinelli J; Fekete M; Tei L; Botta M
    Chem Commun (Camb); 2011 Mar; 47(11):3144-6. PubMed ID: 21270985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.
    Datta A; Raymond KN
    Acc Chem Res; 2009 Jul; 42(7):938-47. PubMed ID: 19505089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Engineering of Self-Immolative Bioresponsive MR Probes.
    Tang JH; Li H; Yuan C; Parigi G; Luchinat C; Meade TJ
    J Am Chem Soc; 2023 May; 145(18):10045-10050. PubMed ID: 37116079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of bioresponsive chelates and perfluorinated lipid nanoparticles enables in vivo MRI probe quantification.
    Gambino G; Gambino T; Angelovski G
    Chem Commun (Camb); 2020 Aug; 56(66):9433-9436. PubMed ID: 32687130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates.
    Aime S; Barge A; Cabella C; Crich SG; Gianolio E
    Curr Pharm Biotechnol; 2004 Dec; 5(6):509-18. PubMed ID: 15579040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of a cell-permeable bimodal contrast agent targeting β-galactosidase.
    Keliris A; Ziegler T; Mishra R; Pohmann R; Sauer MG; Ugurbil K; Engelmann J
    Bioorg Med Chem; 2011 Apr; 19(8):2529-40. PubMed ID: 21459584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
    Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
    MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environment-sensitive and enzyme-sensitive MR contrast agents.
    Querol M; Bogdanov A
    Handb Exp Pharmacol; 2008; (185 Pt 2):37-57. PubMed ID: 18626598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents.
    Lu ZR; Mohs AM; Zong Y; Feng Y
    Int J Nanomedicine; 2006; 1(1):31-40. PubMed ID: 17722260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Magnetic Resonance Imaging with Gd(III)-Based Contrast Agents: Challenges and Key Advances.
    Li H; Meade TJ
    J Am Chem Soc; 2019 Oct; 141(43):17025-17041. PubMed ID: 31593630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
    Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
    Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative imaging of cell-permeable magnetic resonance contrast agents using x-ray fluorescence.
    Endres PJ; Macrenaris KW; Vogt S; Allen MJ; Meade TJ
    Mol Imaging; 2006; 5(4):485-97. PubMed ID: 17150161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivalent protein polymer MRI contrast agents: controlling relaxivity via modulation of amino acid sequence.
    Karfeld-Sulzer LS; Waters EA; Davis NE; Meade TJ; Barron AE
    Biomacromolecules; 2010 Jun; 11(6):1429-36. PubMed ID: 20420441
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.